1 completed, 1 recruiting, 1 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow shuxuening: new trials by email Literature Review of shuxuening trials Research Report on shuxuening
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS) Shuxuening injection or placebo - Subarachnoid Hemorrhage, Aneurysmal | Phase 2 / Phase 3 | Unknown | Xiaolin Chen, MD | 50 | 2024-01-24 | 2024-04-01 |
| Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) Shuxuening Injection, Placebo - Ischemic Stroke, Acute | Phase 3 | Recruiting | Beijing Tiantan Hospital | 1380 | 2024-01-11 | 2025-07-24 |
| Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase Human Urinary Kallidinogenase, Shuxuening injection - Cerebral Infarction | Phase 2 | Completed | XuanwuH 2 | 120 | 2013-01-01 | 2014-10-08 |
Cerebral Infarction (1) · Ischemic Stroke (1) · Subarachnoid Hemorrhage (1)
Beijing Tiantan Hospital (1) · Xiaolin Chen, MD (1) · XuanwuH 2 (1)
China (3)
PMID 11105983, PMID 18211362, PMID 19061352, PMID 19762703, PMID 20798370, PMID 23228346, PMID 24323051, PMID 27637674, PMID 29063300, PMID 41815809